PROFUSA, INC. Other Cash Equivalents, at Carrying Value
PROFUSA, INC. (PFSA) had Other Cash Equivalents, at Carrying Value of $400.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes
us-gaap:OtherCashEquivalentsAtCarryingValue · last filed 2022-11-10
- 2022-09-30: Other Cash Equivalents, at Carrying Value $400.00K.
- 2022-06-30: Other Cash Equivalents, at Carrying Value $500.00K.
- 2022-03-31: Other Cash Equivalents, at Carrying Value $500.00K.
| Period end | Other Cash Equivalents, at Carrying Value |
|---|---|
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $500.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $500.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |